ArticleDiscover oncology2026

Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma.

Ilker Nihat Ökten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.